Quel est le site Web ?

https://www.facebook.com/441296189067402/

The Multilateral Initiative on Malaria - MIM Society

Page d'Accueil
Cameroun
Yaoundé
The Multilateral Initiative on Malaria - MIM Society

The MIM Society is a non-profit organization dedicated to leading malaria research with a prime focus on combating the disease in Africa and beyond.

Our mission is to foster innovative research and collaboration to reduce the burden of malaria globally.

03/09/2025

🦟Mumbai Battles Malaria Surge as Monsoon Cases Spike

Mumbai faces a sharp rise in mosquito-borne diseases this monsoon, with malaria cases jumping to 5,706 (up from 4,021 last year) and chikungunya more than doubling from 210 to 485 cases between January-August 2025. Dengue also increased from 1,979 to 2,319 cases.

Health officials blame heavy rainfall and festive gatherings for the surge. "Currently due to festivities and rainfall, there has been a spike in vector-borne diseases, this is common in August," said a senior BMC officer.

Doctors report more severe complications this year. "Malaria is becoming more severe, affecting kidneys, lungs, and in some cases even the liver," warned Dr Gautam Bhansali of Bombay Hospital, citing poor hygiene, waterlogging, and festival-related contamination as factors making cases more complex.

The Brihanmumbai Municipal Corporation (BMC) has intensified its 'Zero Mosquito Breeding Campaign', covering over 3,200 housing societies, 264 schools, and 545 buildings. Teams actively check stagnant water and breeding spots citywide.

Public advisories urge citizens to use mosquito nets, clear water stagnation, maintain hygiene, avoid wading through floodwaters, and not walk barefoot during heavy rains to reduce infection risk.

01/09/2025

🌟Happy New Month! Welcome to your number 1 Malaria health platform🌟

🦟Africa Health Brief🦟
Zambia: launched its first solar-powered clinic under a $28M program bringing clean energy to 1,277 health facilities across 4 countries, benefiting 1.3M people with reliable vaccine storage and medical equipment power.

Togo: begins malaria vaccination today (Sept 1) with 95% readiness, 325,000+ doses, and upgraded cold storage. The vaccine targets malaria - responsible for 65% of child hospital visits and the top cause of child deaths.

Disease Outbreaks:
Senegal: First 2025 mpox case confirmed in foreign traveler (now stable)
Ghana: Typhoid surge in eastern Oti Region prompts rapid response team deployment
Chad: Cholera epidemic hits 642 cases, 39 deaths in Ouaddaï province; awareness campaigns launched

Research: New safer Rift Valley Fever vaccine in development using non-replicating viral technology, designed for African manufacturing to protect both livestock and humans.

Key trend: Major infrastructure investments (solar clinics) paired with vaccine rollouts addressing Africa's biggest health challenges.

28/08/2025

🌟🦟Burkina Faso Shuts Down Gates-Funded Malaria Research Program🌟🦟

Burkina Faso's government closed Target Malaria, a Gates Foundation-backed research program, following campaigns by anti-Western activists who called it a threat to health sovereignty.

The program, led by Professor Abdoulaye Diabaté, genetically modified male mosquitoes to prevent reproduction of malaria-carrying females. All samples will be destroyed per government order.

Target Malaria received $173 million from Gates Foundation since 2005 and operates in Ghana and Uganda. The shutdown reflects growing anti-Western sentiment under military leader Ibrahim Traoré, who has distanced Burkina Faso from France and moved closer to Russia.

The program aimed to combat malaria, which kills nearly 600,000 people annually, mostly African children. Target Malaria said it was "proud" of its scientific achievements working with local communities since 2012.

27/08/2025

🌟Nigerian Engineer Uses AI Drones to Fight Malaria🌟

Mike Oluwaseun Ojumu, a mechanical engineer from Katsina State, developed autonomous drones with AI-powered spraying systems to target mosquito breeding sites and reduce malaria transmission.

Growing up where malaria was a household constant, Ojumu wanted solutions beyond medicine. He built his first flight controllers from salvaged parts and now uses computer vision and sensors for precision spraying in vulnerable communities.

His drones offer a cost-effective alternative for families who can't afford conventional insecticides. Ojumu advocates for integrating drone technology into Nigerian university STEM programs and calls for local manufacturing partnerships to reduce import dependence.

"From fragments of scrap to life-saving interventions, this journey proves that technology guided by purpose can change lives," he said.

27/08/2025

🌟🦟Western Equatoria Launches First Malaria Vaccine Campaign🌟🦟

Western Equatoria State launched its first malaria vaccination campaign Tuesday in Yambio, targeting children under 5 years old with doses at 6, 7, 8, and 18 months.

Over 40,000 vaccine doses have been distributed across the state, with trained vaccinators in all ten counties. The campaign started in Ibba County and is expanding to Yambio and Nzara.

Malaria kills at least 18 children daily in South Sudan, with 2.8 million cases recorded in 2022. The vaccine is now part of the country's routine immunization program.

Partners including UNICEF, World Vision, and WHO are supporting the rollout to combat South Sudan's leading public health threat.

26/08/2025

🌟🦟Dengue, Malaria Cases Soar in Delhi-NCR After Heavy Rains🌟🦟

Delhi-NCR has become a mosquito breeding ground after this year's monsoon brought 286.7mm of rain in August alone, 25% above normal. Countless stagnant water pools are fueling an alarming early surge in vector-borne diseases, with hospitals reporting higher-than-usual cases of dengue, malaria, and chikungunya.

Dengue cases reached 277 by end-July, among the highest mid-year tallies in five years, then crossed 350 just three weeks later with nearly two dozen new weekly admissions. Last year ended with over 10,585 dengue cases and 11 deaths. Malaria is making a sharp comeback with 124 confirmed cases by late July, already exceeding last year's total—the sharpest rise in nearly a decade. Chikungunya cases remain low at 17 but experts warn of potential flare-ups. Municipal reports found over 9,100 mosquito-larvae-positive sites in just one July week.

Doctors stress early symptom recognition saves lives. Dengue causes sudden high fever, severe headache, eye pain, nausea, muscle aches, and rashes, with severe cases triggering internal bleeding. Chikungunya brings fever with intense joint pain lasting weeks or months. Malaria features recurring fever with chills, sweating, headaches, and fatigue, with severe cases causing breathing issues or organ damage. Seek immediate hospitalization for persistent vomiting, stomach pain, bleeding, breathlessness, or confusion.

Prevention remains the strongest defense: eliminate stagnant water in buckets, tires, and pots; keep containers covered and cleaned; use repellents, nets, and full-sleeved clothing during peak hours; support fumigation drives and report breeding sites promptly. With more September rain forecast, experts warn of another surge, but awareness, prevention, and timely diagnosis can ease hospital burden and save lives.

26/08/2025

🌟🦟Dengue, Malaria Cases Soar in Delhi-NCR After Heavy Rains🌟🦟

Delhi-NCR has become a mosquito breeding ground after this year's monsoon brought 286.7mm of rain in August alone—25% above normal. Countless stagnant water pools are fueling an alarming early surge in vector-borne diseases, with hospitals reporting higher-than-usual cases of dengue, malaria, and chikungunya.

Dengue cases reached 277 by end-July, among the highest mid-year tallies in five years, then crossed 350 just three weeks later with nearly two dozen new weekly admissions. Last year ended with over 10,585 dengue cases and 11 deaths. Malaria is making a sharp comeback with 124 confirmed cases by late July, already exceeding last year's total—the sharpest rise in nearly a decade. Chikungunya cases remain low at 17 but experts warn of potential flare-ups. Municipal reports found over 9,100 mosquito-larvae-positive sites in just one July week.

Doctors stress early symptom recognition saves lives. Dengue causes sudden high fever, severe headache, eye pain, nausea, muscle aches, and rashes, with severe cases triggering internal bleeding. Chikungunya brings fever with intense joint pain lasting weeks or months. Malaria features recurring fever with chills, sweating, headaches, and fatigue, with severe cases causing breathing issues or organ damage. Seek immediate hospitalization for persistent vomiting, stomach pain, bleeding, breathlessness, or confusion.

Prevention remains the strongest defense: eliminate stagnant water in buckets, tires, and pots; keep containers covered and cleaned; use repellents, nets, and full-sleeved clothing during peak hours; support fumigation drives and report breeding sites promptly. With more September rain forecast, experts warn of another surge, but awareness, prevention, and timely diagnosis can ease hospital burden and save lives.

26/08/2025

🌟🦟WHO Endorses Spatial Repellents in Renewed War Against Malaria🌟🦟

The World Health Organization has endorsed spatial repellents as innovative malaria-fighting tools, adding the first new vector control category in 25 years. WHO approved SC Johnson's Guardian™️ and Mosquito Shield™️ repellents as safe, effective interventions available through global health channels.

This follows over a decade of work and $100 million investment by SC Johnson. "This milestone comes after years of relentless effort to protect millions from deadly mosquito-borne diseases," said CEO Fisk Johnson.

Malaria remains devastating with 263 million global cases in 2023 and nearly 600,000 deaths. Africa bears 94% of infections and 95% of deaths, with children under five comprising three-quarters of victims.

These paper-sized devices repel mosquitoes from homes, schools, and semi-enclosed spaces. Clinical trials show they reduce transmission risk by up to 33%, with Guardian offering year-long protection. Unlike bed nets requiring repeated campaigns, spatial repellents are low-cost, long-lasting, and simple to use.

SC Johnson opened high-speed Nairobi manufacturing lines producing 20 million Guardian units annually, with plans to double output to 40 million yearly. Since 2013, their initiatives have reached over 110 million people.

While not a silver bullet, spatial repellents alongside bed nets, medicines, and vaccines could help tip the balance for vulnerable families, potentially helping millions of African children not just survive but thrive.

26/08/2025

🌟🦟Africa: Ministerial Malaria Champions Step Up Fight with New Accountability Scorecard🌟🦟

African Health Ministers at the WHO Regional Committee have issued an urgent call to combat a "perfect storm" threatening malaria progress. Despite a 16% incidence reduction since 2000, Africa carries 95% of the global burden while facing shrinking budgets, drug resistance, invasive mosquitoes, and climate change.

"Malaria is at the frontline of Africa's health security. We must respond with agility or risk reversing hard-won progress," said Dr Mohamed Yakub Janabi, WHO Regional Director for Africa, calling for renewed political will and increased domestic financing.

Current resources cover less than half of global requirements, stressed Dr Michael Adekunle Charles of RBM Partnership to End Malaria, emphasizing the need for bold investment and continued support.

The event unveiled the Malaria Ministerial Champions initiative and Accountability Scorecard, empowering Health Ministers to mobilize resources, drive cross-border collaboration, and scale innovations while tracking progress. Ten Ministers were appointed as Champions this year, with more expected to join.

Botswana's Assistant Health Minister Lawrence Ookediste emphasized opening political space and breaking silos, while Zambia's Dr Elijah Muchima highlighted their End Malaria Council's success in equipping over 18,600 community health workers with bicycles.

Leaders committed to tackling challenges together through political will, accountability, and sustainable financing to reignite Africa's momentum toward malaria elimination.

25/08/2025

🌟🦟13-Year-Old Hospitalized with Malaria After Tanzania Trip🌟🦟

A 13-year-old boy is in serious but stable condition at Sheba Medical Center's ICU after contracting malaria from a mosquito bite during a family vacation in Tanzania. He was admitted Saturday night with high fever and diagnosed with the disease.

Dr. Eyal Leshem, an infectious disease specialist at Sheba, stressed the critical importance of taking preventive malaria medication before traveling to tropical regions, particularly Africa, where disease risk is significantly higher.

The case highlights why medical consultation and prophylactic treatment are essential before international travel to malaria-endemic areas.

14/08/2025

🦟Guinea Launches Historic Malaria Vaccine Program🦟

Guinea has become the 21st African country to introduce the malaria vaccine into its national immunization program. Starting August 2025, approximately 60,000 children aged 5-11 months in four districts will receive the free, four-dose RTS,S vaccine.

The Need:Guinea recorded 4.43 million malaria cases in 2023, with malaria causing over a third of hospital visits and remaining the top killer of children under five.

The Impact:The vaccine, proven successful in Ghana, Kenya, and Malawi, significantly reduces hospitalizations and deaths. Supported by Gavi, WHO, UNICEF, and PATH, it complements existing prevention methods like bed nets.

"Guinea is taking another historic step forward in its fight against malaria," said Health Minister Dr. Oumar Diouhé Bah.

Gavi aims to vaccinate over 50 million African children by 2030, marking a major advance toward health equity across the continent.

12/08/2025

🦟🌟Breakthrough Malaria Vaccine Mimics Natural Immunity🦟🌟

The R21/Matrix-M malaria vaccine produces nearly identical antibodies to those from natural infections, explaining its strong protection against malaria parasites. Research published in the *Journal of Experimental Medicine* shows the vaccine generates the same immune response as natural infection but without causing disease.

The WHO-recommended vaccine targets parasites at their earliest stage when transmitted by mosquito bites, before they reach the bloodstream and cause symptoms. Using advanced sequencing techniques, researchers found vaccinated individuals produced antibodies indistinguishable from those in natural infections, and these antibodies remained effective without needing further adaptation.

"This is exactly what you want to see—that a vaccine elicits the same immune response as a natural infection, but without the malaria parasites causing disease, which still claims more than 600,000 lives a year," said lead researcher Dr. Gregory Ippolito from Texas Biomedical Research Institute.

The vaccine was developed by Oxford's Jenner Institute and the Serum Institute of India, and includes Novavax's Matrix-M adjuvant to boost immune response.

Adresse

Yaoundé

Site Web

facebook.com

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque The Multilateral Initiative on Malaria - MIM Society publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.